Curis
CRIS
#10438
Rank
S$18.98 M
Marketcap
S$0.49
Share price
-8.61%
Change (1 day)
-84.67%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.70. In 2024 the company made an earnings per share (EPS) of S-$9.01 an increase over its 2023 EPS that were of S-$11.57.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-45.9%
2024S-$9.01-22.15%
2023S-$11.57-26.17%
2022S-$15.6822.3%
2021S-$12.82-25.37%
2020S-$17.18-30.93%
2019S-$24.87-2.02%
2018S-$25.38
2016S-$57.68-10%
2015S-$64.09138.1%
2014S-$26.9240%
2013S-$19.23-25%
2012S-$25.6366.67%
2011S-$15.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.68-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.56-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.01-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$4.99 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.41 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.81-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA